These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38299305)

  • 1. Healthcare reform in the Netherlands: after 15 years of regulated competition.
    Maarse H; Jeurissen P
    Health Econ Policy Law; 2024 Feb; ():1-12. PubMed ID: 38299305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results of the market-oriented reform in the Netherlands: a review.
    Maarse H; Jeurissen P; Ruwaard D
    Health Econ Policy Law; 2016 Apr; 11(2):161-78. PubMed ID: 26278627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low institutional trust in health insurers in Dutch health care.
    Maarse H; Jeurissen P
    Health Policy; 2019 Mar; 123(3):288-292. PubMed ID: 30635139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free choice of healthcare providers in the Netherlands is both a goal in itself and a precondition: modelling the policy assumptions underlying the promotion of patient choice through documentary analysis and interviews.
    Victoor A; Friele RD; Delnoij DM; Rademakers JJ
    BMC Health Serv Res; 2012 Dec; 12():441. PubMed ID: 23206601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The key role of health insurance in a cost-effective health care system. Towards regulated competition in the Dutch medical market.
    van de Ven WP
    Health Policy; 1987 Apr; 7(2):253-72. PubMed ID: 10312077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health care reform in The Netherlands: balancing corporatism, etatism, and market mechanisms.
    Schut FT
    J Health Polit Policy Law; 1995; 20(3):615-52. PubMed ID: 8530770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Netherlands: health system review.
    Schäfer W; Kroneman M; Boerma W; van den Berg M; Westert G; Devillé W; van Ginneken E
    Health Syst Transit; 2010; 12(1):v-xxvii, 1-228. PubMed ID: 21132996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing health care market reform through an insurance exchange: essential policy components, the public plan option, and other issues to consider.
    Fronstin P; Ross MN
    EBRI Issue Brief; 2009 Jun; (330):1-22. PubMed ID: 19545086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Managed competition in the health-care services - the Dutch experience].
    Ahrens D
    Gesundheitswesen; 2013 Jun; 75(6):386-92. PubMed ID: 23172597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition policy for health care provision in the Netherlands.
    Schut FT; Varkevisser M
    Health Policy; 2017 Feb; 121(2):126-133. PubMed ID: 27923494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health care reform: managed competition and beyond.
    Custer W
    EBRI Issue Brief; 1993 Mar; (135):1-33. PubMed ID: 10129612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging lessons from regional and state innovation in value-based payment reform: balancing collaboration and disruptive innovation.
    Conrad DA; Grembowski D; Hernandez SE; Lau B; Marcus-Smith M
    Milbank Q; 2014 Sep; 92(3):568-623. PubMed ID: 25199900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferred providers and the credible commitment problem in health insurance: first experiences with the implementation of managed competition in the Dutch health care system.
    Boonen LH; Schut FT
    Health Econ Policy Law; 2011 Apr; 6(2):219-35. PubMed ID: 21122187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Market competition in health care markets in the Netherlands: some lessons for England?
    den Exter AP; Guy MJ
    Med Law Rev; 2014; 22(2):255-73. PubMed ID: 24841530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing the health care market in developing countries: prospects and problems.
    Broomberg J
    Health Policy Plan; 1994 Sep; 9(3):237-51. PubMed ID: 10137740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trust in times of health reform.
    Groenewegen PP; Hansen J; de Jong JD
    Health Policy; 2019 Mar; 123(3):281-287. PubMed ID: 30528656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Managed competition" for Ireland? The single versus multiple payer debate.
    Mikkers M; Ryan P
    BMC Health Serv Res; 2014 Sep; 14():442. PubMed ID: 25261074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consumer choice in Dutch health insurance after reform.
    Maarse H; Meulen RT
    Health Care Anal; 2006 Mar; 14(1):37-49. PubMed ID: 17137018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managed competition in The Netherlands: lessons from five years of health care reform.
    van de Ven W; Rutten F
    Aust Health Rev; 1995; 18(1):9-27. PubMed ID: 10141966
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.